CHERYL STOMBERG: Open Payments
NPI 1003500661 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $458
Food & beverage: $374Education: $84
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| Janssen Biotech, Inc. | 1 | $84 |
| Kite Pharma, Inc. | 2 | $43 |
| Janssen Scientific Affairs, LLC | 2 | $40 |
| Adaptimmune LLC | 1 | $24 |
| Legend Biotech USA Inc. | 1 | $20 |
Products named: DARZALEX, IMDELLTRA (AMG757), Yescarta, CARVYKTI.
Industry payments across OR — which companies pay providers there.
